Immune Thrombocytopenic Purpura (ITP) Latest Advances

Chaperone-mediated autophagy reprograms heterogeneous subsets of activated macrophages in immune thrombocytopenia.

Journal: Autophagy

Published: June 22, 2026

Experimental models of anti-PF4 immunothrombosis: mechanistic insights, translational value, and unmet needs.

Journal: Thrombosis and haemostasis

Published: June 15, 2026

Efgartigimod as a Steroid-sparing Therapy for Evans Syndrome: A Case Report.

Journal: Internal medicine (Tokyo, Japan)

Published: June 10, 2026

Clinical characteristics, management strategies, and outcomes of pediatric immune thrombocytopenic purpura: a five-year single-center experience.

Journal: European review for medical and pharmacological sciences

Published: June 04, 2026

Clinical Significance of CCRL2 Regulating Platelet Function in Pediatric Chronic Immune Thrombocytopenia

Journal: Zhongguo shi yan xue ye xue za zhi

Published: June 02, 2026

Sirolimus-based treatment regimens for antinuclear antibody (ANA)-positive immune thrombocytopenia: a retrospective single-center cohort study.

Journal: Hematology (Amsterdam, Netherlands)

Published: May 25, 2026

The hunt for a cure: modern medical approaches for immune thrombocytopenia.

Journal: Expert review of hematology

Published: May 20, 2026

Association between vaccine-induced immune thrombocytopenia and thrombosis and human leucocyte antigen loci: Yes, no or maybe?

Journal: British journal of haematology

Published: May 19, 2026

Shared Inflammatory Gene Programs between Immune Thrombocytopenia and CKD-Related Autoimmune Nephropathies: An Exploratory Transcriptomic and Bioinformatic Study.

Journal: Balkan journal of medical genetics : BJMG

Published: May 18, 2026

Rilzabrutinib for persistent or chronic immune thrombocytopenia (ITP): a Bruton tyrosine kinase inhibitor that can target multiple pathophysiological pathways.

Journal: Expert review of hematology

Published: May 10, 2026

Correction to: Treatment outcomes and prognostic indicators of primary immune thrombocytopenia in 31 cats: a multicenter retrospective study (2000-2023).

Journal: Journal of veterinary internal medicine

Published: May 06, 2026

In-vitro diagnostics of adult immune thrombocytopenia - status quo and new developments.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: May 06, 2026

Immune Thrombocytopenic Purpura (ITP) Latest Advances

Find the Latest Research About Immune Thrombocytopenic Purpura (ITP)

Chaperone-mediated autophagy reprograms heterogeneous subsets of activated macrophages in immune thrombocytopenia.

Chaperone-mediated autophagy reprograms heterogeneous subsets of activated macrophages in immune thrombocytopenia.

Experimental models of anti-PF4 immunothrombosis: mechanistic insights, translational value, and unmet needs.

Experimental models of anti-PF4 immunothrombosis: mechanistic insights, translational value, and unmet needs.

Efgartigimod as a Steroid-sparing Therapy for Evans Syndrome: A Case Report.

Efgartigimod as a Steroid-sparing Therapy for Evans Syndrome: A Case Report.

Clinical characteristics, management strategies, and outcomes of pediatric immune thrombocytopenic purpura: a five-year single-center experience.

Clinical characteristics, management strategies, and outcomes of pediatric immune thrombocytopenic purpura: a five-year single-center experience.

Clinical Significance of CCRL2 Regulating Platelet Function in Pediatric Chronic Immune Thrombocytopenia

Clinical Significance of CCRL2 Regulating Platelet Function in Pediatric Chronic Immune Thrombocytopenia

Sirolimus-based treatment regimens for antinuclear antibody (ANA)-positive immune thrombocytopenia: a retrospective single-center cohort study.

Sirolimus-based treatment regimens for antinuclear antibody (ANA)-positive immune thrombocytopenia: a retrospective single-center cohort study.

The hunt for a cure: modern medical approaches for immune thrombocytopenia.

The hunt for a cure: modern medical approaches for immune thrombocytopenia.

Association between vaccine-induced immune thrombocytopenia and thrombosis and human leucocyte antigen loci: Yes, no or maybe?

Association between vaccine-induced immune thrombocytopenia and thrombosis and human leucocyte antigen loci: Yes, no or maybe?

Shared Inflammatory Gene Programs between Immune Thrombocytopenia and CKD-Related Autoimmune Nephropathies: An Exploratory Transcriptomic and Bioinformatic Study.

Shared Inflammatory Gene Programs between Immune Thrombocytopenia and CKD-Related Autoimmune Nephropathies: An Exploratory Transcriptomic and Bioinformatic Study.

Rilzabrutinib for persistent or chronic immune thrombocytopenia (ITP): a Bruton tyrosine kinase inhibitor that can target multiple pathophysiological pathways.

Rilzabrutinib for persistent or chronic immune thrombocytopenia (ITP): a Bruton tyrosine kinase inhibitor that can target multiple pathophysiological pathways.

Correction to: Treatment outcomes and prognostic indicators of primary immune thrombocytopenia in 31 cats: a multicenter retrospective study (2000-2023).

Correction to: Treatment outcomes and prognostic indicators of primary immune thrombocytopenia in 31 cats: a multicenter retrospective study (2000-2023).

In-vitro diagnostics of adult immune thrombocytopenia - status quo and new developments.

In-vitro diagnostics of adult immune thrombocytopenia - status quo and new developments.